| Ronn A Grandia, MD | |
|
12075 Jerrys Run Rd, Apple Grove, WV 25502 | |
| (304) 546-0854 | |
| Not Available |
| Full Name | Ronn A Grandia |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 38 Years |
| Location | 12075 Jerrys Run Rd, Apple Grove, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720032238 | NPI | - | NPPES |
| 310917085052 | Other | OH | CARESOURCE MEDICAID |
| 000901380 | Other | MOUNTAIN STATE BCBS | |
| 000000181638 | Other | OH | UNISON MEDICAID |
| 0848051 | Other | OH | MOLINA MEDICAID |
| 0848051 | Medicaid | OH | |
| 1720032238 | Medicaid | WV | |
| 000000211735 | Other | ANTHEM BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 35-06-1980 (Ohio) | Secondary |
| 208600000X | Surgery | 18530 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pleasant Valley Hospital | Point pleasant, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Point Pleasant Physician Billing Services | 3375538184 | 29 |
News Archive
By adding the results of an imaging technique to the traditional risk factors for coronary heart disease, doctors at Baylor College of Medicine in Houston found they were able to improve prediction of heart attacks in people previously considered low risk.
Researchers from the Centenary Institute have discovered a potential new therapy for cerebral cavernous malformations, a devastating disease that often affects young people and can result in stroke and seizures.
The U.S. Food and Drug Administration today approved the first nucleic acid test for hepatitis B virus (HBV) that measures the amount of viral DNA (viral load) in a patient's blood. Assessing a patient's viral load provides health care professionals with a highly sensitive method for gauging the progress of antiviral therapy in patients with chronic HBV infections.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013.
Researchers at Aalto University and the University of Helsinki have succeeded for the first time ever in affecting metacognition of a tactile working memory task by combining neural pathway imaging and magnetic stimulation of the brain.
› Verified 4 days ago
| Entity Name | Point Pleasant Physician Billing Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798898 PECOS PAC ID: 3375538184 Enrollment ID: O20040419001780 |
News Archive
By adding the results of an imaging technique to the traditional risk factors for coronary heart disease, doctors at Baylor College of Medicine in Houston found they were able to improve prediction of heart attacks in people previously considered low risk.
Researchers from the Centenary Institute have discovered a potential new therapy for cerebral cavernous malformations, a devastating disease that often affects young people and can result in stroke and seizures.
The U.S. Food and Drug Administration today approved the first nucleic acid test for hepatitis B virus (HBV) that measures the amount of viral DNA (viral load) in a patient's blood. Assessing a patient's viral load provides health care professionals with a highly sensitive method for gauging the progress of antiviral therapy in patients with chronic HBV infections.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013.
Researchers at Aalto University and the University of Helsinki have succeeded for the first time ever in affecting metacognition of a tactile working memory task by combining neural pathway imaging and magnetic stimulation of the brain.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronn A Grandia, MD Po Box B, Fraziers Bottom, WV 25082-0251 Ph: () - | Ronn A Grandia, MD 12075 Jerrys Run Rd, Apple Grove, WV 25502 Ph: (304) 546-0854 |
News Archive
By adding the results of an imaging technique to the traditional risk factors for coronary heart disease, doctors at Baylor College of Medicine in Houston found they were able to improve prediction of heart attacks in people previously considered low risk.
Researchers from the Centenary Institute have discovered a potential new therapy for cerebral cavernous malformations, a devastating disease that often affects young people and can result in stroke and seizures.
The U.S. Food and Drug Administration today approved the first nucleic acid test for hepatitis B virus (HBV) that measures the amount of viral DNA (viral load) in a patient's blood. Assessing a patient's viral load provides health care professionals with a highly sensitive method for gauging the progress of antiviral therapy in patients with chronic HBV infections.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013.
Researchers at Aalto University and the University of Helsinki have succeeded for the first time ever in affecting metacognition of a tactile working memory task by combining neural pathway imaging and magnetic stimulation of the brain.
› Verified 4 days ago